Ilios Therapeutics
PrivateLast Round
Seed
Sep 5, 2023
Company Overview
Ilios Therapeutics is a biotechnology company that has built a chemistry platform to generate multi-functional, brain-penetrant small molecules rationally-designed to combat neurodegenerative diseases such as ALS, Alzheimer's, and Parkinson's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ilios Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Ilios Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 5, 2023 | ||||
| Grant | Apr 1, 2022 |
Ilios Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Allston Venture Fund | Grant |
| Club degli Investitori | Seed |
| Catalisi | Seed |
| MassChallenge | Grant |
| InnoSpark Ventures | Seed |
| Exor Ventures | Seed |
| 3LB Seed Capital | Seed |
Ilios Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ilios Therapeutics's valuation, stock price, and market status.
